These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 35246897)

  • 1. Developing electronic monitor adapters for dermatologic medication containers: A methods paper.
    Shah PM; Balogh EA; Van Gorkom AR; Brown PJ; Feldman SR
    Skin Res Technol; 2022 Mar; 28(2):371-373. PubMed ID: 35246897
    [No Abstract]   [Full Text] [Related]  

  • 2. Adherence in dermatology.
    Ahn CS; Culp L; Huang WW; Davis SA; Feldman SR
    J Dermatolog Treat; 2017 Mar; 28(2):94-103. PubMed ID: 27180785
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dermatologic medication adherence.
    Nolan BV; Feldman SR
    Dermatol Clin; 2009 Apr; 27(2):113-20, v. PubMed ID: 19254654
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Timing of office visits can be a powerful tool to improve adherence in the treatment of dermatologic conditions.
    Heaton E; Levender MM; Feldman SR
    J Dermatolog Treat; 2013 Apr; 24(2):82-8. PubMed ID: 23432428
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessing adherence to dermatology treatments: a review of self-report and electronic measures.
    Greenlaw SM; Yentzer BA; O'Neill JL; Balkrishnan R; Feldman SR
    Skin Res Technol; 2010 May; 16(2):253-8. PubMed ID: 20456106
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adapting electronic adherence monitors to standard packages of topical medications.
    Tusa MG; Ladd M; Kaur M; Balkrishnan R; Feldman SR
    J Am Acad Dermatol; 2006 Nov; 55(5):886-7. PubMed ID: 17052499
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association Between Method of Prescribing and Primary Nonadherence to Dermatologic Medication in an Urban Hospital Population.
    Adamson AS; Suarez EA; Gorman AR
    JAMA Dermatol; 2017 Jan; 153(1):49-54. PubMed ID: 27784045
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Electronic monitoring in medication adherence measurement. Implications for dermatology.
    Koehler AM; Maibach HI
    Am J Clin Dermatol; 2001; 2(1):7-12. PubMed ID: 11702622
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmionics in dermatology: a review of topical medication adherence.
    Lee IA; Maibach HI
    Am J Clin Dermatol; 2006; 7(4):231-6. PubMed ID: 16901183
    [TBL] [Abstract][Full Text] [Related]  

  • 10. We must think outside the box to understand nonadherence.
    Dabade TS; Feldman SR
    Pediatr Dermatol; 2011; 28(3):353. PubMed ID: 21615479
    [No Abstract]   [Full Text] [Related]  

  • 11. Long-term safety of biologics in dermatology.
    Lima XT; Seidler EM; Lima HC; Kimball AB
    Dermatol Ther; 2009; 22(1):2-21. PubMed ID: 19222513
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antimetabolites and cytotoxic drugs.
    Silvis NG
    Dermatol Clin; 2001 Jan; 19(1):105-18, viii-ix. PubMed ID: 11155576
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Choosing dermatologic therapies.
    Wilkin J
    Dermatol Ther; 2009; 22(3):187-90. PubMed ID: 19453341
    [No Abstract]   [Full Text] [Related]  

  • 14. Poor adherence to oral and topical medication in 3096 dermatological patients as assessed by the Morisky Medication Adherence Scale-8.
    Furue M; Onozuka D; Takeuchi S; Murota H; Sugaya M; Masuda K; Hiragun T; Kaneko S; Saeki H; Shintani Y; Tsunemi Y; Abe S; Kobayashi M; Kitami Y; Tanioka M; Imafuku S; Abe M; Inomata N; Morisky DE; Katoh N
    Br J Dermatol; 2015 Jan; 172(1):272-5. PubMed ID: 25154923
    [No Abstract]   [Full Text] [Related]  

  • 15. Prescription-level factors associated with primary nonadherence to dermatologic medications.
    Rutherford A; Glass DA; Suarez EA; Adamson AS
    J Dermatolog Treat; 2018 May; 29(3):300-304. PubMed ID: 28783420
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [What's new in pediatric dermatology?].
    Stalder JF
    Ann Dermatol Venereol; 2007 Dec; 134 Suppl 1():8S36-52. PubMed ID: 18675140
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Key developments in dermatology.
    Smith V; Sharpe G
    Practitioner; 2005 Jun; 249(1671):398, 400, 402 passim. PubMed ID: 15966274
    [No Abstract]   [Full Text] [Related]  

  • 18. Dermatologic medication in pregnancy.
    Turcić P; Bukvić Mokos Z; Jurakić Toncić R; Blagaić V; Lipozencić J
    Acta Dermatovenerol Croat; 2009; 17(1):40-7. PubMed ID: 19386214
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Poor adherence to medication as assessed by the Morisky Medication Adherence Scale-8 and low satisfaction with treatment in 237 psoriasis patients.
    Saeki H; Imafuku S; Abe M; Shintani Y; Onozuka D; Hagihara A; Katoh N; Murota H; Takeuchi S; Sugaya M; Tanioka M; Kaneko S; Masuda K; Hiragun T; Inomata N; Kitami Y; Tsunemi Y; Abe S; Kobayashi M; Morisky DE; Furue M
    J Dermatol; 2015 Apr; 42(4):367-72. PubMed ID: 25720544
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Reflections about non compliance].
    Consoli SG
    Ann Dermatol Venereol; 2012 Jan; 139 Suppl 1():S28-32. PubMed ID: 22305284
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.